1/90
Kawasaki disease, rheumatic fever, cardiomyopathy, ineffective endocarditis, hypertension, obesity/hyperlipidemia
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
Kawasaki Disease
Acute febrile illness with systemic vasculitis (inflammation of blood vessels)
Affects all vessels, especially coronary arteries
Major risk: coronary artery aneurysms → thrombosis → myocardial infarction
aka = Mucocutaneous Lymph Node Syndrome
Kawasaki Disease - Etiology & Risk Factors
Unknown cause
Likely:
Genetic predisposition
Possible infectious trigger
Not contagious
More common:
< 5 years old (76%)
Males
Winter & spring
Asian/Pacific Island descent
Kawasaki Disease - Diagnosis
Diagnosis of exclusion (no specific test)
Required Criteria
Fever ≥ 5 days (>100.4°F / 39°C)
PLUS 4 of the following:
Extremity changes (redness, swelling, peeling)
Polymorphous rash
Bilateral conjunctivitis (no pus)
Oral changes (strawberry tongue, cracked lips)
Cervical lymphadenopathy (>1.5 cm)
Kawasaki Disease - Acute Phase (Week 1)
High fever
Irritability
Inflammation → joint pain
Kawasaki Disease - Subacute Phase (Weeks 2–3)
Peeling skin (hands/feet)
↑ Platelets (thrombocytosis) → ↑ clot risk
Risk of:
Coronary aneurysms
Thrombus → MI
Kawasaki Disease - Lab Findings (Supportive, not diagnostic)
↑ WBC (leukocytosis)
↑ Platelets (thrombocytosis)
↑ ESR & CRP (inflammation)
↑ liver enzymes
Mild anemia
Kawasaki Disease - Complications
Coronary artery aneurysms (15–25%)
Thrombosis
Myocardial ischemia/infarction
Kawasaki Disease - Treatment
Main Goals
Reduce inflammation
Prevent coronary damage
Primary Treatments
IVIG (Intravenous Immunoglobulin)
Dose: 2 g/kg
May repeat if fever persists
Aspirin Therapy
High dose: 80–100 mg/kg/day (acute phase)
Then low dose: 3–5 mg/kg/day
Continued 6–8 weeks or longer if coronary involvement
Kawasaki Disease - Supportive Care
Antipyretics (fever control)
IV fluids (hydration)
Monitor intake (child often irritable)
Kawasaki Disease - Prognosis
With treatment:
~90% have normal coronary arteries by 6–18 months
Without treatment:
High risk of cardiac complications
Rheumatic Fever
Autoimmune inflammatory disease
Occurs after untreated group A beta-hemolytic streptococcal (GAS) pharyngitis
Causes inflammation in:
Heart (most serious)
Joints
Brain
Blood vessels
Rheumatic Fever - Cause & Pathophysiology
Trigger: strep throat infection
Occurs about ~10 days after infection
Immune system overreacts → attacks body tissues
Leads to progressive damage to heart valves (especially left side)
Rheumatic Fever - Who Is Affected
Ages: 6–15 years (peak ~8 years)
Higher risk:
Genetically susceptible children
Limited access to healthcare (untreated strep)
Rheumatic Fever - Diagnosis: Jones Criteria (
Diagnosis requires:
2 major OR
1 major + 2 minor
Rheumatic Fever - Major Manifestations
Carditis (most serious)
Often mitral valve insufficiency
Polyarthritis
Painful, swollen joints (migratory)
Sydenham chorea
Involuntary movements
Facial grimacing, poor coordination
Erythema marginatum
Pink, non-itchy rash (trunk)
Subcutaneous nodules
Firm nodules over bony areas
Rheumatic Fever - Minor Manifestations
Fever (>38.5°C)
Arthralgia (joint pain)
↑ ESR / CRP
Prolonged PR interval (ECG)
Rheumatic Fever - Key Clinical Features
Polyarthritis → common first sign
Carditis (~50%) → can cause permanent damage
Chorea (~10%) → worsens with stress
Rash (rare but specific) → erythema marginatum
Rheumatic Fever - Lab & Diagnostic Findings
↑ ASO titer → confirms recent strep infection
↑ ESR, CRP (inflammation)
Echocardiogram → essential
Evaluates heart valve damage
Rheumatic Fever - Complications
Chronic rheumatic heart disease
Valve damage (mitral most common)
Possible need for:
Valve repair
Valve replacement
Rheumatic Fever - Antibiotics
Penicillin (IM or oral for 10 days)
Started immediately after labs obtained
Rheumatic Fever - Anti-inflammatory Therapy
NSAIDs → reduce joint pain & inflammation
Steroids → for severe carditis (controversial)
Rheumatic Fever - Chorea Management
Medications:
Phenobarbital
Diazepam
Rheumatic Fever - Prognosis
Depends on heart involvement
Valve damage may:
Progress over time
Appear later even if absent initially
Requires lifelong cardiology follow-up
Cardiomyopathy
Disease of the heart muscle
Major cause of heart failure (HF) in children
#1 cause of heart transplant in children >1 year
Causes:
Primary: genetic, neuromuscular
Secondary: infection, toxins, structural disease, metabolic disorders
Dilated Cardiomyopathy
Enlarged (dilated) left ventricle
↓ systolic function (weak contraction)
Often → mitral valve regurgitation
Dilated Cardiomyopathy - Key Causes
Genetic (up to 50%)
Myocarditis (usually viral) → most common inflammatory cause
Cardiotoxic drugs (chemotherapy)
Radiation therapy
Dilated Cardiomyopathy - Pathophysiology
Weak heart muscle → poor pumping
Blood backs up → heart failure symptoms
LV dilation → valve stretching → regurgitation
Dilated Cardiomyopathy - Children CM
Exercise intolerance
Dyspnea on exertion
Chest pain
Palpitations
Syncope
Severe Cases
Cardiogenic shock (rapid onset)
Dilated Cardiomyopathy - Infants CM
Respiratory distress
Poor feeding
Fatigue
Dilated Cardiomyopathy - Diagnostic Findings
CXR:
Cardiomegaly
Pulmonary congestion/edema
ECG:
Sinus tachycardia
Echocardiogram (KEY):
Dilated ventricle
↓ systolic function
Dilated Cardiomyopathy - Medication
ACE inhibitors
Beta-blockers
RAAS inhibition
→ Goal: manage heart failure symptoms
Dilated Cardiomyopathy - Advanced Therapy
ECMO (temporary support)
VAD (ventricular assist device)
Heart transplant (if severe, refractory)
Dilated Cardiomyopathy - Prognosis
~50% recover within first year (if survival occurs)
Remaining:
25% → improved but abnormal function
25% → severe persistent dysfunction
Outcome depends on:
Age
Cause
Overall health
Hypertrophic Cardiomyopathy
Thickened (hypertrophied) left ventricle
Small (nondilated) ventricular cavity
Hypercontractile systolic function
Impaired relaxation (diastolic dysfunction)
Hypertrophic Cardiomyopathy - Key Feature
In ~20%:
Left ventricular outflow tract (LVOT) obstruction
Caused by mitral valve moving toward septum
→ Called Hypertrophic Obstructive Cardiomyopathy (HOCM)In ~20%:
Left ventricular outflow tract (LVOT) obstruction
Caused by mitral valve moving toward septum
→ Called Hypertrophic Obstructive Cardiomyopathy (HOCM)
Hypertrophic Cardiomyopathy - Etiology
Autosomal dominant genetic disorder
Most common inherited cardiac condition
Up to 80% have a family history
→ Family screening required
Hypertrophic Cardiomyopathy - Major Risk
Most common cause of sudden cardiac death in healthy children/athletes
Death usually due to:
Arrhythmias
↑ myocardial oxygen demand
Hypertrophic Cardiomyopathy - Special Case
Infants of diabetic parents:
Develop temporary HCM due to hyperinsulinism
Usually resolves within 1 year
Hypertrophic Cardiomyopathy - CM
Exercise intolerance
Syncope (fainting)
Dyspnea
Chest pain
Infants
Signs of heart failure
Important
Many children are asymptomatic
Hypertrophic Cardiomyopathy - Diagnosis
Echocardiogram (KEY)
Shows LV hypertrophy
May show obstruction
Hypertrophic Cardiomyopathy - Beta-blockers
(FIRST LINE)
Example: metoprolol
Effects:
↓ heart rate
↓ contractility
↓ oxygen demand
↑ ventricular filling
Hypertrophic Cardiomyopathy - Calcium Channel Blockers
Example: verapamil
Improve diastolic filling
Hypertrophic Cardiomyopathy - Advanced Treatment
Surgical removal of obstruction (if severe)
Implantable Cardioverter-Defibrillator (ICD)
For high-risk patients
Prevents sudden cardiac death
Hypertrophic Cardiomyopathy - Nursing / Safety Considerations
Avoid dehydration
↓ preload → worsens obstruction
Monitor for:
Syncope
Arrhythmias
Encourage family screening
Restrictive Cardiomyopathy
Stiff (noncompliant) ventricles
Impaired filling during diastole
Normal (or near normal) systolic function
Normal wall thickness
Restrictive Cardiomyopathy - Key Pathophysiology
Heart cannot relax properly
↓ ventricular filling → ↓ preload
→ ↓ cardiac output
Leads to heart failure (HF)
Restrictive Cardiomyopathy - Causes
Idiopathic (unknown)
Can be associated with:
Other systemic diseases
Rare
Accounts for ~2.5–5% of cardiomyopathies
Restrictive Cardiomyopathy - CM
(Often related to poor filling & HF)
Exercise intolerance
Fatigue
Dyspnea
Signs of heart failure
May resemble right-sided HF:
Hepatomegaly
Edema
Restrictive Cardiomyopathy - Key Concept
“Normal squeeze, poor filling”
→ opposite problem of dilated cardiomyopathy
Restrictive Cardiomyopathy - Diagnosis
Echocardiogram (KEY)
Normal systolic function
Impaired diastolic filling
Prognosis
Poor
~50% mortality within 2 years
Restrictive Cardiomyopathy - Management
Mainly supportive
Focus on:
Managing HF symptoms
May ultimately require:
Heart transplant
Arrhythmogenic Right Ventricular Cardiomyopathy
Rare inherited heart disease
Characterized by:
Fibrofatty replacement of the right ventricle
Leads to:
Electrical instability → ventricular arrhythmias
Arrhythmogenic Right Ventricular Cardiomyopathy - Key Pathophysiology
Heart muscle cells die and are replaced with fat & fibrous tissue
Disrupts electrical conduction
→ Causes ventricular tachyarrhythmias
Often triggered by exercise
Arrhythmogenic Right Ventricular Cardiomyopathy - Major Risk
Sudden cardiac death, especially in:
Young people
Athletes
Arrhythmogenic Right Ventricular Cardiomyopathy - CM
Palpitations
Syncope (fainting)
Chest pain
Sudden cardiac arrest (especially during exercise)
⚠ RED FLAG:
Any symptoms during exercise → must be evaluated immediately
Arrhythmogenic Right Ventricular Cardiomyopathy - Diagnosis
Patient & family history
12-lead ECG
Echocardiogram
Cardiac MRI (important for structural changes)
Arrhythmogenic Right Ventricular Cardiomyopathy - Management
(No cure — focus on prevention of death)
Lifestyle
Restrict physical activity/exercise
Prognosis
Variable but risk of sudden death is significant
Requires lifelong monitoring
Arrhythmogenic Right Ventricular Cardiomyopathy - Medications
Beta-blockers
Antiarrhythmic drugs
Arrhythmogenic Right Ventricular Cardiomyopathy - Device Therapy
Implantable Cardioverter-Defibrillator (ICD)
Most important intervention
Prevents sudden cardiac death
Cardiomyopathy Comparison Table
Feature | Dilated (DCM) | Hypertrophic (HCM) | Restrictive (RCM) | ARVC |
|---|---|---|---|---|
Main Problem | Weak, stretched heart | Thick, stiff heart | Stiff, noncompliant heart | Electrical instability |
Ventricle Size | Dilated (enlarged) | Thick, small cavity | Normal size | RV replaced by fat |
Systolic Function | ↓ Decreased | ↑/Normal (hypercontractile) | Normal | Variable |
Diastolic Function | ↓ | ↓ | ↓ (MAIN issue) | Variable |
Key Patho | Poor contraction | Poor relaxation + obstruction | Poor filling | Fibrofatty RV replacement |
Most Common Cause | Genetic, myocarditis | Genetic (autosomal dominant) | Idiopathic/systemic | Genetic |
Classic Symptoms | HF, fatigue, dyspnea | Syncope, chest pain, exercise intolerance | HF symptoms | Palpitations, syncope |
Infant Symptoms | Poor feeding, fatigue | HF symptoms | HF symptoms | Rare early |
Hallmark Clue | Big weak heart | Thick heart + sudden death | Normal squeeze, poor filling | Exercise → arrhythmia |
Major Risk | Heart failure | Sudden cardiac death | Severe HF, high mortality | Sudden cardiac death (athletes) |
Diagnosis | Echo: dilated LV | Echo: thick LV | Echo: stiff ventricles | ECG + MRI |
Treatment | HF meds, transplant | Beta-blockers, ICD | Supportive, transplant | ICD, avoid exercise |
Prognosis | Variable | Risk of sudden death | Poor (50% in 2 yrs) | Variable, high risk death |
DCM = “DILATED = DEAD PUMP”
Big heart
Weak squeeze
→ Heart failure
HCM = “HUGE HEART = HARD TO FILL”
Thick muscle
Sudden death in athletes
→ Think syncope during exercise
RCM = “RESTRICTED FILLING”
Normal squeeze
Can’t fill
→ worst prognosis
ARVC = “ARRHYTHMIA + ATHLETE”
Exercise-triggered
Sudden death
→ ICD needed
Infective Endocarditis
Infection + inflammation of the endocardium (inner heart lining) and valves
Often occurs in children with:
Congenital heart disease (CHD)
Indwelling lines (e.g., PICC)
Infective Endocarditis - Causes
Most common organisms:
Staphylococcus aureus
Streptococcus viridans
Infective Endocarditis - Pathophysiology
Endothelial damage (CHD or catheter)
Platelets + fibrin deposit → clot forms
Bacteria enter bloodstream
Bacteria stick to clot → vegetation forms
Valve damage + infection spreads
Infective Endocarditis - Acute IE (FAST & SEVERE) CM
High fever
Toxic/very ill appearance
Heart failure symptoms
New or worsening murmur
Infective Endocarditis - Subacute IE (SLOW) CM
Low-grade fever
Fatigue
Weight loss
Malaise
Joint pain
Night sweats (diaphoresis)
Infective Endocarditis - Diagnostic Findings
Positive blood cultures
Echocardiogram:
Vegetations
Valve damage
Labs:
↑ ESR
Leukocytosis
Anemia
Hematuria / proteinuria
Infective Endocarditis - Treatment
V antibiotics for 4–6 weeks
Given via PICC line
Based on culture sensitivity
Severe cases:
Valve damage → surgery or valve replacement
Infective Endocarditis - Complications
Heart valve destruction
Heart failure
Emboli → kidneys (renal damage)
Chronic valve disease
Infective Endocarditis - Prophylaxis
Antibiotics BEFORE dental procedures if:
Prosthetic heart valve
Previous IE
High-risk CHD:
Unrepaired cyanotic CHD
Recent repair (<6 months)
Residual defects
Heart transplant with valve disease
Hypertension
Elevated blood pressure based on:
Age
Gender
Height percentile
Must be confirmed on 3 separate occasions
Hypertension - Risk Factors
Overweight / abdominal obesity
High salt intake
Male sex
Older age (adolescents)
Family history
Social determinants of health
Hypertension - Primary Hypertension
Most common in older children/adolescents
Causes:
Genetics
Lifestyle (diet, inactivity)
Hypertension - Secondary Hypertension
Caused by underlying condition:
Renal disease (most common cause in kids)
Cardiac disorders
Pulmonary disorders
Neurologic conditions
Medications
Hypertension - Classification
Ages 1–13 years
Normal: <90th percentile
Prehypertension: 90th–<95th percentile
Hypertension: ≥95th percentile
≥13 years (use adult values)
Normal: <120/80
Prehypertension: 120–129/<80
Stage 1 HTN: 130–139 / 80–89
Stage 2 HTN: ≥140/90
Hypertension - Assessment & Diagnosis
Proper BP Measurement
Use correct cuff size:
Width = 40% of arm
Length = covers full circumference
Measure in right arm
Arm at heart level
If high reading → repeat manually
Additional Evaluation
History + family history
Physical exam
Possible tests:
Labs (renal function)
Imaging if secondary cause suspected
24-hour ambulatory BP monitoring (more accurate)
Hypertension - Complications
Early cardiovascular disease
Left ventricular hypertrophy
Early atherosclerosis
Hypertension - Management
First-line (LIFESTYLE CHANGES)
Weight reduction
Regular physical activity
Healthy diet (↓ salt)
Sleep hygiene
Avoid smoking/alcohol
Family-based interventions ↑ success
Hypertension - Medications
ACE inhibitors
ARBs
Beta-blockers
Calcium channel blockers
Diuretics
Vasodilators
👉 Monitor for side effects
Dyslipidemia
Abnormal levels of:
Cholesterol
LDL (bad fat)
HDL (good fat)
Triglycerides
Leads to early atherosclerosis → future cardiovascular disease
Dyslipidemia - Risk Factors
Obesity
Diabetes
Hypertension
Family history of early heart disease:
Male <55 years
Female <65 years
Renal disease
Some congenital heart diseases
Why It Matters
Atherosclerosis begins in childhood
Risk factors in kids → adult heart disease
Dyslipidemia - Screening Guidelines
Universal Screening
Ages 9–11
Ages 17–21
Early Screening (Ages 2–8) if:
Family history of dyslipidemia/early CVD
Obesity (BMI >95th percentile)
Diabetes or hypertension
Dyslipidemia - Diet Therapy
CHILD-1 Diet
Low fat
Low saturated fat
Low cholesterol
→ If no improvement after 3 months:
CHILD-2 Diet
More restrictive diet
Dyslipidemia - Medications
Statins (if ≥10 years old)
Monitoring on Statins:
Liver enzymes (hepatic transaminases)
Creatine kinase (CK)
Watch for muscle toxicity
Overweight & Obesity in Children
Overweight: ≥85th percentile
Obesity: ≥95th percentile
~1 in 3 children in the U.S. are overweight or obese
Prevalence has:
Tripled (ages 2–5, 12–19)
Quadrupled (ages 6–11)
Obesity - Why It Matters
Major risk factor for:
Cardiovascular Disease
Hypertension
Dyslipidemia
Leads to lifelong complications:
Physical (diabetes, heart disease)
Psychological (low self-esteem, depression)
Social + economic impact
Obesity - Causes (Multifactorial)
Poor diet (high fat, high sugar)
Sedentary lifestyle
Excess screen time
Family habits
Genetic predisposition
Obesity - Management (FIRST-LINE = Lifestyle)
Nutrition
Low-fat diet
Eliminate sugary drinks
Reduce processed/sugary foods
Activity
Increase daily physical activity
Reduce sedentary behavior
Screen Time
Limit TV, phones, gaming
Family-Based Approach
Whole family must participate
Improves long-term success